Future Directions in the Management of Malignant Bone Tumors

摘要: In spite of the considerable improvements produced by combination chemotherapy, there remain many problems still to be tackled in order enhance survival rate patients with primary malignant bone tumors. There is some evidence that current chemotherapy programs have reached a plateau their effect on survival, and further are going difficult both obtain detect. This chapter describes remaining discusses possibilities for advancement. The increasing specialization treatment tumors has had advantage that, countries, expertise been concentrated few major centers. means national international collaboration clinical trials should become easier if agreement can nature questions posed.